Current Position: Product Center
Anti-CD3×CD20 hIgG1 Bispecific Antibody (Epcobio)
Cat. No.
GM-88130MAB
Size
Quote
Related products
基本信息
Cat. No. & Size
Description
Data
Related products
基本信息

Cat.No:GM-88130MAB

Product:Anti-CD3×CD20 hIgG1 Bispecific Antibody (Epcobio)



Cat. No. & Size

GM-88130MAB-1mg / 1 mg

GM-88130MAB-5mg / 5 mg

GM-88130MAB-25mg / 5 mg * 5 vials

GM-88130MAB-50mg / 50 mg

GM-88130MAB-100mg / 50 mg * 2 vials



Description

Expression System

CHO

Aggregation

< 5% as determined by SEC-HPLC

Purity

> 95% as determined by SDS-PAGE

Endotoxin

< 1 EU/mg, determined by LAL gel clotting assay

Sterility

0.2 μm Filtered

Target

CD3&CD20

Clone

Epcoritamab

Alternative Names

CD3: ALPS5,CD,CD152,CELIAC3,CTLA-4,GRD4, GSE, IDDM12

CD20: CD279, PD-1, PDCD1, SLEB2, hPD-1, hPD-l, hSLE1

Source/Isotype

Human IgG1 K214R/L234F/L235E/D265A /D356E/L358M/delta447K kappa;

Human IgG1 K214R/L234F/L235E/D265A/D356E/L358M/delta447K lambda2

Application

Activation assay

Description

Epcoritamab (also known as EP-C1 or ABBV-181) is a novel bispecific antibody that primarily targets the B cell surface antigens CD3 and CD20. By bringing T cells and tumor cells together, it facilitates the activation of T cells and enhances the anti-tumor immune response.

Formulation

phosphate-buffered solution, pH 7.2-7.4.



Data

image.png

image.png

image.png


Anti-CD3×CD20 hIgG1 Bispecific Antibody (Epcobio)
Cat. No.
GM-88130MAB
Size
Quote
Related products
基本信息
Cat. No. & Size
Description
Data
Related products
基本信息

Cat.No:GM-88130MAB

Product:Anti-CD3×CD20 hIgG1 Bispecific Antibody (Epcobio)



Cat. No. & Size

GM-88130MAB-1mg / 1 mg

GM-88130MAB-5mg / 5 mg

GM-88130MAB-25mg / 5 mg * 5 vials

GM-88130MAB-50mg / 50 mg

GM-88130MAB-100mg / 50 mg * 2 vials



Description

Expression System

CHO

Aggregation

< 5% as determined by SEC-HPLC

Purity

> 95% as determined by SDS-PAGE

Endotoxin

< 1 EU/mg, determined by LAL gel clotting assay

Sterility

0.2 μm Filtered

Target

CD3&CD20

Clone

Epcoritamab

Alternative Names

CD3: ALPS5,CD,CD152,CELIAC3,CTLA-4,GRD4, GSE, IDDM12

CD20: CD279, PD-1, PDCD1, SLEB2, hPD-1, hPD-l, hSLE1

Source/Isotype

Human IgG1 K214R/L234F/L235E/D265A /D356E/L358M/delta447K kappa;

Human IgG1 K214R/L234F/L235E/D265A/D356E/L358M/delta447K lambda2

Application

Activation assay

Description

Epcoritamab (also known as EP-C1 or ABBV-181) is a novel bispecific antibody that primarily targets the B cell surface antigens CD3 and CD20. By bringing T cells and tumor cells together, it facilitates the activation of T cells and enhances the anti-tumor immune response.

Formulation

phosphate-buffered solution, pH 7.2-7.4.



Data

image.png

image.png

image.png


Message consultation
reset
submit
Message
Message consultation
reset
submit